Eden Research (LON:EDEN) Trading Down 3.3% – Time to Sell?

Eden Research plc (LON:EDEN) fell 3.3% on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company’s 50-day simple moving average is GBX 3.87 and its 200-day simple moving average is GBX 3.95. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insider Activity

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of the stock in a transaction dated Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek purchased 256,000 shares of the business’s stock in a transaction that occurred on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.